Acquisition

June 24, 2026 Listing Department Department of Corporate Services National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeebhoy Towers Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: MEDIASSIST Scrip Code: 544088 Dear Sir/ Madam, Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Reg: Acquisition of additional shares of Mayfair We Care Limited, UK - a subsidiary of the Company We would like to inform that the Board of Directors of the Company at their meeting held today i.e., June 24, 2026 have approved a further investment of INR equivalent to GBP 589,270 (Great Britain Pounds Sterling Five Hundred Eighty-Nine Thousand Two Hundred Seventy only) as of the remittance date for the additional acquisition of 31.75% shares of Mayfair We Care Limited, UK (“Mayfair”), subsidiary of the Company. The acquisition shall be executed via share transfer from existing shareholders of Mayfair and upon completion of this transaction, the Company’s total shareholding in Mayfair shall increase from 60% to 91.75% of its issued share capital. Mr. Nikhil Chopra — currently serving as the Chief Business Officer for the Company, and Director of Mayfair — will be appointed as the CEO-designate for Mayfair and shall take over as CEO of Mayfair upon completion of the acquisition, subject to receipt of all requisite approvals. Concurrently, Mr. Michail Chopra will transition from his role as CEO of Mayfair to the role Founder & Strategic Advisor. Both appointments shall become effective upon completion of all formalities relating to the transaction. The requisite details in relation to the aforesaid acquisition, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III are enclosed as an Annexure. The Board Meeting commenced at 02:25 PM and concluded at 02.55 PM. This is also being uploaded on the website of the Company at www.mediassist.in. You are requested to take the same on record. For Medi Assist Healthcare Services Limited Rashmi B V Company Secretary & Compliance Officer Membership No: A38729 Annexure Details required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 # Particulars Details a) Name of the target entity, details Mayfair We Care Limited, UK (“Mayfair”) provides health claim in brief such as size, turnover etc. and health benefits administration services focused on the global health insurance market. The turnover and net profit of Mayfair as on March 31, 2026 is as under: a) Turnover: INR 410.85 Million. b) Net Profit (After Tax): INR 16.31 Million. b) Whether the acquisition would fall Yes, Mayfair is an existing subsidiary of the Company. The within related party transaction(s) transaction is done at arm’s length basis. and whether the promoter/ promoter group/ group companies Except to the extent of shares held by the Company in Mayfair, have any interest in the entity the Company has no interest in Mayfair. being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length c) Industry to which the entity being Insurance intermediary acquired belongs d) Objects and impact of acquisition The additional acquisition of 31.75% of the shareholding of (including but not limited to, Mayfair is aligned with the terms and conditions of the existing disclosure of reasons for SHA and SPA entered between the parties. acquisition of target entity, if its business is outside the main line of This transaction deepens the Company's foothold in business of the listed entity) international markets and is consistent with its long-term vision of delivering seamless, cross-border health administration. By consolidating direct leadership over Mayfair's operations, the Company aims to drive greater operational efficiency and capitalize on emerging global opportunities. e) Brief details of any governmental Not applicable or regulatory approvals required for the acquisition f) Indicative time period for Expected to close acquisition of 31.75% by end of 2nd quarter completion of the acquisition of FY 2026-27, subject to completion of customary closing formalities g) Consideration - whether cash Cash consideration consideration or share swap or any Proposed to be funded from the proceeds raised through other form and details of the same preferential allotment allocated towards ‘general corporate purposes’. The utilization of such proceeds for the additional investment is in line with the objects approved by the shareholders and there is no deviation from the objects of the issue. h) Cost of acquisition and/or the price The shares shall be acquired for INR equivalent to GBP 589,270 at which the shares are acquired as of the remittance date. i) Percentage of shareholding/ Acquisition of 1,270 ordinary shares, representing 31.75% of control acquired and/ or number the shareholding of Mayfair. of shares acquired Upon completion of this acquisition, the Company's aggregate shareholding in Mayfair shall increase from 60% to 91.75% of its total issued share capital. j) Brief background about the entity Brief background and line of Business: acquired in terms of products/line Mayfair is a subsidiary of the Company and provides health of business acquired, date of claim and health benefits administration services focused on incorporation, history of last 3 the global health insurance market. years turnover, country in which the acquired entity has presence Date of incorporation: October 22, 2015, (Registered with the and any other significant UK Companies House under Company Number 09836998) information (in brief) History of last 3 years turnover: (Amount in INR Million) March-24 March-25 March-26 363.69 367.27 410.85 *****